Research and Innovation Hub BioPharma Cluster South Germany
A strong corporate landscape, innovative research facilities and extensive investment in research, development and production characterise the location.
Renowned international companies such as Boehringer Ingelheim Pharma, Rentschler Biopharma, Sartorius Stedim Cellca, Teva and Vetter Pharma are among the approximately 100 life science companies based in the region.
Educational and Research Landscape
The BioPharma Cluster South Germany comes with a high concentration of public and private research facilities, focusing on research programmes in the field of red biotechnology.
The medicine of the future will be even more precise and targeted. In order to make precision medicine a reality, biopharmaceuticals are indispensable, especially the next generation of active biopharmaceutical substances. In the future, the BioPharma Cluster will promote and further expand its research activities to facilitate a successful transfer of scientific findings to all areas of society – thus making new and advanced treatments available to patients.
Ulm University and Biberach University of Applied Sciences partner with other departments and international universities, offering the framework of various research associations and networks and helping research and development projects benefit from their broad scientific knowledge.
Excellent research conditions and versatile career and training opportunities make the BioPharma Cluster attractive to highly skilled professionals, further expanding the region’s research excellence and strengthening its innovative capacities.
Growth and Knowledge Transfer Enable Global Top Position
The BioPharma Cluster has established itself as one of the most important European locations for developing and producing biopharmaceuticals and plays a vital role in helping German biopharmacy have international value. The region in southern Germany between the City of Ulm and Lake Constance operates at eye-level with the world's leading biotechnology hubs in Boston, San Francisco, and Singapore. In the long term, the BioPharma Cluster seeks to enhance the quality of its research, positioning itself competitively.
The aim is to strengthen the region’s leading position and achieve technology leadership for the next generation of biopharmaceuticals. By doing so, the BioPharma Cluster contributes to maintaining Germany’s global competitiveness as innovation leader and biopharmaceutical location. For this to happen, research must go hand in hand with economic utilisation of the results. With its close-knit network of research institutions and its diversified corporate landscape, the BioPharma Cluster has set the course for successful knowledge sharing.
Our regional players are at the heart of a robust business and research ecosystem that offers ideal conditions for developing and producing innovative biopharmaceutical products. Industrial and academic partners decided to join forces to further advance basic research into safe and effective treatments that meet medical need. By intensifying the collaboration, the BioPharma Cluster lays the foundation for confidently entering the era of next-generation biopharmaceutical manufacturing and successfully delivering breakthrough medicines to people with severe diseases.
The BioPharma Cluster benefits from an excellent infrastructure powered by strong partners committed and highly qualified to introducing the next generation of biopharmaceuticals to the market and becoming a global leader in this future field.
Further LifeScience Research
Der SFB 1279
Core Unit Massenspektrometrie and Proteomics
Core Facility Functional Peptidomics